Royal London Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$173M |
| 2 |
Core Laboratories
CLB
|
+$170M |
| 3 |
Everest Group
EG
|
+$87.1M |
| 4 |
RenaissanceRe
RNR
|
+$70.9M |
| 5 |
Royal Caribbean
RCL
|
+$69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$161M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$109M |
| 3 |
Chevron
CVX
|
+$99.7M |
| 4 |
Verizon
VZ
|
+$89.4M |
| 5 |
Boeing
BA
|
+$77.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.99% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 13.32% |
| 4 | Consumer Discretionary | 13.05% |
| 5 | Industrials | 8.56% |
Similar funds
Royal London Asset Management's Q3 2018 Portfolio in Review
As of Q3 2018, Royal London Asset Management held 586 positions worth $9.77B, down 1.8% from $9.94B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Royal London Asset Management withdrew a net $808M in Q3 2018, closing 73 positions and reducing 329 holdings. Its most notable exit was JPMorgan Chase, an estimated $161M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Royal London Asset Management opened a new position in Abiomed Inc worth $7.25M.
- Royal London Asset Management's largest Q3 2018 buy was Abiomed Inc: 16,122 shares worth $7.25M.
- Royal London Asset Management added most to NXP Semiconductors in Q3 2018, an estimated $173M increase.
- Royal London Asset Management's biggest Q3 2018 reduction was Apple, cutting an estimated $24.5M.
- Royal London Asset Management fully exited JPMorgan Chase in Q3 2018, selling an estimated $161M.
- Royal London Asset Management's ten largest holdings make up 25% of its $9.77B portfolio in Q3 2018.
- Royal London Asset Management opened 6 new positions and closed 73 in Q3 2018.
- Royal London Asset Management's portfolio value fell 1.8% quarter-over-quarter to $9.77B.
Based on Royal London Asset Management's 13F filing for Q3 2018, filed 8 Nov 2018.